Aggrecan Antikörper
Kurzübersicht für Aggrecan Antikörper (ABIN187628)
Target
Alle Aggrecan (ACAN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Reacts with chondroitin sulfate proteoglycan from cartilage (aggrecan). Species Reactivity: Reacts with human. No crossreactivity with bovine nasal cartilage, rat chondrosarcoma, chick or shark cartilage aggrecan. Other species not tested. Controls: Purified antigen, cartilage extracts or mature cultured chondrocytes.
-
Immunogen
- Human large molecular weight proteoglycan of articular cartilage (aggrecan).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA: 1:500-1:1,000 (highest ELISA reactivity of our 3 anti-chondroitin/keratan sufate proteoglycans). In solid phase immunoassays, endo-beta-galactosidase digestion of aggrecan increases the immunoreactivity of the antibody. Also reacts with papain-digested aggrecan. Immunohistochemistry: (paraffin embedded): 1:50-1:3,000. Treat tissue sections with 2 mg/ml testicular hyaluronidase in 50 mM Na-acetate buffer, pH 5.5 for 1 hr at 37C, followed by treatment with 0.2 mg/ml Protease XXIV in TBS, pH 7.2, for the same time and temperature. Immunoprecipitation: 1:50-1:300 Western blotting: 1:100-1:300 Reacts with 3 trypsin-generated fragments of human cartilage aggrecan (prior digested with chondroitinase and endo-beta-galactosidase) which have apparent MW of 55, 65 and 95 kDa. The optimal dilution for a specific application should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 100 µl ascites containing 0.01% sodium azide. Antibody concentration >1 mg/ml.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
-
- Aggrecan (ACAN)
-
Andere Bezeichnung
- Aggrecan
-
Pathways
- Glycosaminoglycan Metabolic Process, Dicarboxylic Acid Transport
Target
-